ClinicalTrials.Veeva

Menu

Westeinde Brachialgia Study (WEB)

M

Medical Center Haaglanden

Status

Completed

Conditions

Radiculopathy, Cervical

Treatments

Other: cervical collar
Other: physiotherapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The Westeinde Brachialgia Study (WEB) is a randomized controlled trial to establish the effect of cervical collar or physiotherapy compared to a wait-and-see policy in patients with acute cervical radiculopathy.

Full description

Cervical radiculopathy caused by spondylosis or disc protrusion is a common disorder with a usually benign natural course. Often, physiotherapy (exercise programs) and/or cervical collar are prescribed. However, there are no reliable data on the effects of these conservative therapies.

In this study, patients with acute cervical radiculopathy, defined by clinical criteria, are randomized for cervical collar, physiotherapy or a wait-and-see policy.

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cervical radiculopathy defined by neck pain irradiating to one arm with at least one of the following: provocation by neck movements or sensory changes in one or more adjacent dermatomes or diminished deep tendon reflexes in the affected arm; or muscle weakness in one or more adjacent myotomes.

Exclusion criteria

  • Arm pain existing longer than one month
  • Clinical signs of spinal cord compression
  • Previously treated with physiotherapy or a cervical collar

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

240 participants in 3 patient groups

wait and see
No Intervention group
collar
Experimental group
Treatment:
Other: cervical collar
physiotherapy
Experimental group
Treatment:
Other: physiotherapy

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems